top of page
UNIFIED Image

Putting the Patient Voice at the Centre of Healthcare Decisions

Healthcare decisions shape people’s lives. They influence which treatments are developed, approved, reimbursed, and ultimately made available to patients. Yet too often, the outcomes used in clinical studies do not fully reflect what matters most to patients in their everyday lives.  

UNIFIED exists to change that.

UNIFIED stands for Unifying Framework for Patient Centred Clinical Study Endpoints Derived from Digital Health Technologies. The project brings together partners from academia, clinicians, patient organisations, industry, health technology assessment bodies, and regulators across Europe, Canada, and the United States.  

Our shared ambition is clear. Clinical evidence should reflect what truly matters to patients.  

WHAT UNIFIED AIMS TO ACHIEVE

UNIFIED is developing the UNIFIED Framework, a harmonised and internationally aligned approach to integrating patient centred endpoints into clinical studies and healthcare decision making.  

 

The Framework focuses on three key components:

Patient preferences information

Clinical outcome assessments

Digital health technology-derived measures

By bringing these elements together in a structured and evidence based way, UNIFIED aims to support more holistic clinical and economic evaluation of medical products and technologies. ​

 

This means helping ensure that healthcare decisions are informed not only by traditional clinical indicators, but also by outcomes that capture how patients feel, function, and experience treatment in daily life.

FROM RESEARCH TO REAL WORLD
APPLICATION

UNIFIED will test and refine the framework through use cases in five medical areas:​

Paediatric Radiation Oncology

Paediatric Radiation Oncology

Lung Cancer

Lung Cancer

Parkinson's Disease

Parkinson's Disease

Obesity

Obesity

Juvenile Idiopathic Arthritis

Juvenile Idiopathic Arthritis

These diverse areas allow the project to explore how patient centred endpoints can be applied across different conditions, age groups, and healthcare contexts.  

 

The goal is to deliver practical guidance and consensus based recommendations that can be used by researchers, companies, regulators, HTA bodies, and clinicians.  

A GLOBAL PUBLIC PRIVATE PARTNERSHIP

UNIFIED is funded under the Innovative Health Initiative, a Horizon Europe public private partnership that brings together the European Union and industry to tackle complex health challenges.  

 

The project is coordinated by Erasmus University Rotterdam as Coordinator and Public Lead, in collaboration with Pfizer as Industry Lead, and a consortium of 40 partners. Together, the consortium combines methodological expertise, clinical knowledge, digital innovation, regulatory insight, and lived experience.  

WHY UNIFIED MATTERS

Calls for patient involvement in healthcare are not new. What is new is the opportunity to systematically integrate patient perspectives into the way clinical evidence is generated and evaluated.

 

Digital health technologies make it possible to capture outcomes in new ways. Advances in patient preference research help clarify what patients value most. Policy momentum across Europe supports more patient centred approaches.  

 

UNIFIED builds on this momentum.  

 

By developing a shared framework and clear recommendations, the project aims to ensure that measures reflecting what matters to patients are no longer the exception. They become part of standard practice in healthcare decision making.

 

Because healthcare should start and end with the patient.  

Interested in the UNIFIED project or have a question for our team? Get in touch or follow our updates on social media.

 

 

Email: info@unified-project.eu

  • Linkedin
  • Youtube
IHI Logo
EuropaBio Logo
EU Logo
COCIR Logo
EFPIA Logo
MedTech Europe Logo
Vaccines Europe Logo
GenAIz Logo
John Snow Labs

This project is supported by the Innovative Health Initiative Joint Undertaking (IHI JU) under grant agreement No 101218845. The JU receives support from the European Union’s Horizon Europe research and innovation programme and COCIR, EFPIA, Europa Bío, MedTech Europe, Vaccines Europe, GenAIz, and John Snow Labs Inc.    

 

Funded by the European Union, the private members, and those contributing partners of the IHI JU. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the aforementioned parties. Neither of the aforementioned parties can be held responsible for them.  

© 2026 by Collaborate Project Management GmbH.

bottom of page